Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hitomi, Onomoto"'
Autor:
Junko Ikemoto, Satoshi Yoshihara, Izumi Yamashita, Mao Tsujimoto, Fuka Yamaguchi, Yuki Harada, Hiroki Sugiyama, Shinya Otsuka, Rie Murata, Hitomi Onomoto, Noriko Okuda, Risa Takao, Asuka Ikegami, Mari Suita, Ayaka Uemura, Mariko Kawaguchi, Kyoko Yoshihara, Kenichi Yamahara, Satoshi Higasa
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 68:533-538
Autor:
Kenichi Yamahara, Junko Ikemoto, Noriko Okuda, Rie Murata, Hitomi Onomoto, Shinya Otsuka, Hiroki Sugiyama, Yuki Harada, Akiko Hamada, Satoshi Yoshihara, Satoshi Higasa
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 68:17-22
Autor:
Shinya Otsuka, Junko Ikemoto, Kyoko Yoshihara, Mao Tsujimoto, Fuka Yamaguchi, Yuki Harada, Hiroki Sugiyama, Hitomi Onomoto, Rie Murata, Noriko Okuda, Kenichi Yamahara, Satoshi Higasa, Satoshi Yoshihara
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 67:597-600
Autor:
Katsuji Kaida, Yuko Osugi, Satoshi Higasa, Keiko Fukunaga, Kenichi Yamahara, Hiroya Tamaki, Kazuhiro Ikegame, Junko Ikemoto, Masaya Okada, Hitomi Onomoto, Satoshi Yoshihara, Kyoko Yoshihara, Hiroki Sugiyama, Yoshihiro Fujimori, Noriko Okuda
Publikováno v:
Transfusion Medicine. 31:365-370
OBJECTIVES To determine the impact of the use of hydroxyethyl starch (HES) in granulocyte apheresis using Spectra Optia. BACKGROUND Granulocyte transfusion (GT) is a therapeutic option for neutropenic patients with severe bacterial or fungal infectio
Autor:
Tomoyasu Jo, Satoshi Yoshihara, Asuka Hada, Yasuyuki Arai, Toshio Kitawaki, Junko Ikemoto, Hitomi Onomoto, Hiroki Sugiyama, Kyoko Yoshihara, Natsuno Obi, Keiko Matsui, Norimi Niwa, Yoko Nakagawa, Junya Kanda, Tadakazu Kondo, Satoshi Saida, Itaru Kato, Hidefumi Hiramatsu, Souichi Adachi, Junko Takita, Akifumi Takaori-Kondo, Miki Nagao
Publikováno v:
Transplantation and Cellular Therapy. 28(7):365.e1-365.e7
As chimeric antigen receptor (CAR) T cell therapy targeting CD19 has shown favorable outcomes in patients with relapsed or refractory (r/r) mature B cell lymphomas and B cell acute lymphoblastic leukemia (B-ALL), an increasing number of patients are
Autor:
Tomoyasu, Jo, Satoru, Yoshihara, Yasuyuki, Arai, Junko, Ikemoto, Hitomi, Onomoto, Hiroki, Sugiyama, Kyoko, Yoshihara, Keiko, Matsui, Norimi, Niwa, Yoko, Nakagawa, Toshio, Kitawaki, Junya, Kanda, Akifumi, Takaori-Kondo, Miki, Nagao
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 62(3)
To perform chimeric antigen receptor T (CAR-T) cell therapy in heavily pretreated patients with progressive disease and depleted lymphocytes, an optimized leukapheresis protocol must be established. To probe the effects of patient-related parameters